🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Canada / NCT05384561
Recruiting Not applicable

Olfactory Training as a Treatment for Olfactory Dysfunction Post COVID-19

NCT05384561 · tracked via the Priya Life Science Canada tracker
Phase
Not applicable
Started
2022-05-31
Last updated
2026-07-31

Condition(s) studied

HyposmiaCOVID-19ParosmiaAnosmiaSARS-CoV-2 Infection

Investigational drug(s) / intervention(s)

Smell training

Smell training: For 12 weeks, morning and evening, smell four different odors or four odorless substances for a total of five minutes per session.

Study summary

Olfactory dysfunction is a defining symptom of COVID-19 infection. Studies have demonstrated improved olfaction in patients with post infectious olfactory dysfunction after an olfactory training (OT). The aim of this study is to assess the clinical outcomes of olfactory training (12 weeks) therapy in the treatment of persistent olfactory dysfunctions after COVID-19. Specially, we aim to compare the effectiveness of two different olfactory training (different odors).

A group will train themselves with 4 scents (rose, orange, clove and eucalyptus) and another group with 4 different scents (cheese, coffee, strawberries and lemon). Olfaction sensory evaluation will be performed by using different olfaction tests (Sniffin' Sticks and UPSIT) and complete questionnaires to assess olfactory perception and particularly parosmia and phantosmia.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patient diagnosed positive for COVID-19 with persistent olfactory dysfunction * Willing and able to provide written informed consent * Understand and read the French language * Have an internet connection and a working email address Exclusion Criteria: * Anosmia and hyposmia pre-covid-19 * Be known chronic rhinosinusitis with or without nasal polyposis * Have received radiotherapy or chemotherapy for Head and Neck Tumors * Have a diagnosis of Alzheimer's, Parkinson's, multiple sclerosis or any other neurodegenerative disease 5. Have a brain tumor or ENT diagnosis 6. History of naso-sinus surgery; 7. History of traumatic brain injury

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Université du Québec à Trois-Rivières Trois-Rivières Quebec Recruiting

More Université du Québec à Trois-Rivières trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05384561 on ClinicalTrials.gov ↗ ← All trials in Canada